GSK plc 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-20 4:12 pm Sale | 2022-09-16 | 13D | Theravance Biopharma, Inc. TBPH | GSK plc | 0 0.000% | -9,644,807 (Position Closed) | Filing |
| 2022-08-03 08:33 am Unchanged | 2022-08-03 | 13D | Theravance Biopharma, Inc. TBPH | GSK plc | 9,644,807 12.700% | 0 (Unchanged) | Filing |
| 2022-02-10 4:48 pm Unchanged | 2021-11-08 | 13D | Theravance Biopharma, Inc. TBPH | GSK plc | 9,644,807 13.100% | 0 (Unchanged) | Filing |